Top 5 Medical Device Angel Investors in Belgium

Last updated: Aug 2024 A list of 5 angel investors that invest in Medical device startups based in Belgium. We rank investors based on the number of investments they made in Medical device companies from Belgium. We update this investor list every month.

Top 5 Medical Device Angel Investors in Belgium

Investor	Medical Device Belgium investments
Pierre Rigaux	3
Yves Beudin	1
Pierre Drion	1
Jean Dessain	1
Eduardo Ronzano	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Pierre Rigaux

Investment focus

Sports, Medical Device
Seed, Pre-Seed, Convertible Note
Belgium

Portfolio highlights

MYOCENE — Myocene is a Liège-based sports technology company which creates unique and innovative devices for measuring muscle fatigue and performance.

Yves Beudin

Investment focus

Medical, Health Care, Biotechnology
Angel
Belgium

Portfolio highlights

OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.

Pierre Drion - CEO @ Petercam

Investment focus

Biotechnology, Health Care, Life Science
Series A, Series B, Funding Round
Belgium

Portfolio highlights

A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
Santero Therapeutics — Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance. Santero develops antimicrobials with novel modes of action to combat the rise of antibiotic-resistant microorganisms.

Jean Dessain - Non Executive Director @ OneLIFE

Investment focus

Medical, Health Care, Biotechnology
Angel
Belgium

Portfolio highlights

OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.

Eduardo Ronzano is the Co-Founder and CEO of Kolet. He previously worked at The Bradery as a Pre-Seed Investor. Eduardo Ronzano attended ESCP Business School.